Eucrisa gained approval based on two trials involving over 1,500 patients with mild-to-moderate eczema, showing the ointment was more effective than placebo in achieving clear or almost clear skin ...

Dermatologists may recommend non-steroidal options—such as topical calcineurin inhibitors (TCIs), phosphodiesterase inhibitors (Eucrisa), or janus kinase inhibitors (Opzelura)—for eczema ...